Showing 1 to 2 of 2 results


FDA Approves First New Painkiller in Over Two Decades
The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, though further research on chronic pain is needed.
FDA Approves First New Painkiller in Over Two Decades
The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, though further research on chronic pain is needed.
Progress
40% Bias Score

FDA Approves First New Pain Reliever in Over Two Decades
The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, but further research is needed for chronic pain.

FDA Approves First New Pain Reliever in Over Two Decades
The FDA approved Journavx (suztrigine), a new non-opioid pain reliever, offering a safer alternative to opioids; clinical trials showed effectiveness in reducing post-surgical pain, but further research is needed for chronic pain.
Progress
48% Bias Score
Showing 1 to 2 of 2 results